- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
NEW YORK ( TheStreet) -- Santarus (Nasdaq: SNTS) hit a new 52-week high Thursday as it is currently trading at $24.46, above its previous 52-week high of $24.43 with 1.4 million shares traded as of 2:05 p.m. ET. Average volume has been 1.4 million shares over the past 30 days. Santarus has a market cap of $1.51 billion and is part of the health care sector and drugs industry. Shares are up 112.5% year to date as of the close of trading on Wednesday. Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists.